News - MiGenTra

Cookie and data protection information

This website uses cookies & third-party applications to enable certain functions and to improve the offer.

Essenziell

Contao HTTPS CSRF Token

Schützt vor Cross-Site-Request-Forgery Angriffen.

Retention period: Dieses Cookie bleibt nur für die aktuelle Browsersitzung bestehen.

PHP SESSION ID

Speichert die aktuelle PHP-Session.

Retention period: Dieses Cookie bleibt nur für die aktuelle Browsersitzung bestehen.

Analytics

Third party applications for analysis purposes for our website

Google Analytics

Provider: Google Ireland Ltd., Gordon House, Barrow Street, Dublin 4, Ireland

Retention period: More about sessions duration https://policies.google.com/privacy.

Data Protection

Skip navigation

Company
Capabilities
Facilities
Careers
News
Contact

Company
Capabilities
Facilities
Careers
News
Contact

Press Releases

Nov 03, 2022

MiGenTra Highlights How Biosimilars Are Transforming Healthcare in Africa at the Festival of Biologics

download PDF

May 18, 2022

MiGenTra Marks One-Year Anniversary by Attending Africa Health ExCon 2022

download PDF

Mar 07, 2022

Lutz Hilbrich Appointed as Senator to the Senate of Economy Europe

download PDF

Mar 02, 2022

Product Development Company MiGenTra Announces Formation of International Advisory Board

download PDF

May 27, 2021

ProBioGen and Minapharm Pharmaceuticals incorporate MiGenTra GmbH – A Healthcare Transforming Medicines Company

download PDF

Press Contact

Sarah Wandrey, Corporate Communications

Sarah Wandrey
Corporate Communications
Phone: +49 (0) 30 3229 35 144
Email: press@probiogen.de

MiGenTra GmbH

Headquarters
Herbert-Bayer-Straße 4
13086 Berlin, Germany
Phone: +49 (0) 30 5771 4380
Email: info@migentra.com

Follow us

Copyright © 2021 MiGenTra GmbH
Legal Notice | Disclaimer | Data Protection